{"name":"Wen Zhang","slug":"wen-zhang","ticker":"","exchange":"","domain":"","description":"Wen Zhang is a Chinese actor. He graduated from the Central Academy of Drama in 2006. He is known for his roles in television series Struggle (2007), Dwelling Narrowness (2009), and in films Ocean Heaven (2010), Love is Not Blind (2011), and Journey to the West: Conquering the Demons (2013).","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"prednison","genericName":"prednison","slug":"prednison","indication":"Acquired thrombocytopenia","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"T 614","genericName":"T 614","slug":"t-614","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"prednison","genericName":"prednison","slug":"prednison","phase":"marketed","mechanism":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","indications":["Acquired thrombocytopenia","Acute lymphoid leukemia","Adrenal cortical hypofunction","Adrenogenital disorder","Allergic rhinitis"],"catalyst":""},{"name":"T 614","genericName":"T 614","slug":"t-614","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTFA4RXViNFFVUERTNEJZOGNpVkY0dldTbVdHUjlVX2hwam9oMHNaMVZUZUVOa01Zc3RaQVBDOEtqa25iVjlIZW5SLVdxb0x3YnVGQm1OWTZRSlYzSWQ4eTZWRkxZaUpFWFRrSmw2WHl0Tl9qbTN1OWc?oc=5","date":"2026-02-07","type":"pipeline","source":"Wiley","summary":"Cu Single Atom Stabilized Au Nanoclusters on TiO2 for Efficient Hydrogen Production - Wiley","headline":"Cu Single Atom Stabilized Au Nanoclusters on TiO2 for Efficient Hydrogen Production","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1UZUlVa1dvREJxMXU2YmFuUWtYVzFkRjN1dENrUlJZS2dib2dwczY3N01EcjVIampFN204aHU0SHMtWmZIaGs3VlEzVDJjUDdXMnBhM3F3aWpSSmlFNTVZ?oc=5","date":"2024-06-05","type":"pipeline","source":"Science | AAAS","summary":"Chemical conjugation mitigates immunotoxicity of chemotherapy via reducing receptor-mediated drug leakage from lipid nanoparticles - Science | AAAS","headline":"Chemical conjugation mitigates immunotoxicity of chemotherapy via reducing receptor-mediated drug leakage from lipid nan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOTDV1LUdFTDBEVV9GUXRWd0Y4Rk1LMjZNdHllUjRMWk5ubExmYVcxWHNGRU9ISkY0WnJ5SHBvMEF0YjFxNVRzVG0zREhYZHpXbXhaX1pFM1daRVVsd283YjZLbEtpWW5FU2pvX085WnM4RDVLVnlkLXVLdjY2bVM5Qkw2TmJaR25IbTM3LTFPNW41MjNjU3dFcFF0U3ctUXRa?oc=5","date":"2024-04-22","type":"pipeline","source":"travis.af.mil","summary":"Living the American dream: Paying it forward - travis.af.mil","headline":"Living the American dream: Paying it forward","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE9aVmZxN3JpZmVUY0Q2bDk0UGc5ZVBRNlNSbFYwaTNVMC1Tb3hiUmRaUEFkd1hmQ2xIYXR1TVRtSHE0UGUzbDc2T2hqaXlmSTJ6dld2WHp4SDd5Skg5Z0ozQU53MC10Mkt1U1Zj?oc=5","date":"2023-08-29","type":"pipeline","source":"Wiley Online Library","summary":"The progress of fabrication designs of polymeric microneedles and related biomedical applications - Wiley Online Library","headline":"The progress of fabrication designs of polymeric microneedles and related biomedical applications","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE9NTjNWRE5iYXBTR0NOS21vSWhzekpMclRtMVZNZGN1RE50VE1xWDh0Mm8tTEdNcmpITmxfQ1J5Qm9JUmJNMjg0UUVTR2d6YVktMzF1dXNzSjdvc3Jvb3MtSTBUanBMY1k?oc=5","date":"2023-03-17","type":"pipeline","source":"ACS Publications","summary":"Arylation of Cyclopropanol with Pyrrole: Asymmetric Synthesis of Indolizidine 167B, Indolizidine 209D, and Monomorine I - ACS Publications","headline":"Arylation of Cyclopropanol with Pyrrole: Asymmetric Synthesis of Indolizidine 167B, Indolizidine 209D, and Monomorine I","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNYjJPMnBucFBFaUZ2bjE3NkJHQ2V1QnhXY0xDZDVEZFJ1N3FxQXp4OElURlFfYllJaG03MklOcUxTWlVINXc0UXJJSjIzazR3QkptT29GeXVIaXd1eWhXYWwxT3JHRG82azRJQXZESUVJX0U4TXMxVjhPcHNQRzJlbVAxcGNxTnBXVWVrWUdqWFdFRDhY?oc=5","date":"2023-01-05","type":"pipeline","source":"Cornell Chronicle","summary":"Electrochemistry converts carbon to useful molecules - Cornell Chronicle","headline":"Electrochemistry converts carbon to useful molecules","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOTEtLQmlpVlhYaTVaWU9RNkFPY0hkRk1LbEo0ZW1vcDhQSk5NUGRFMFdnY09zMzhpMTEyUmZYQTBHX2hEanlkTjdNV1gxXzJKTTZ2LTF2aWlZcC05czYxUElpd0NqMWVWXzUwSlcwRHNJbWViXzBDYzRpcUR6Wng3Rm10c054XzRJYi00RGxYaFQ?oc=5","date":"2022-09-28","type":"pipeline","source":"Frontiers","summary":"Natural products targeting human lactate dehydrogenases for cancer therapy: A mini review - Frontiers","headline":"Natural products targeting human lactate dehydrogenases for cancer therapy: A mini review","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxOTlVYLXhycUYwNHpXbFpjc3ZzeEF5cDJLVlJsMFlnRHU0dmREcW9FOFpacjR0S1RyUHZzcGlkQkNWMXlTVnFnRjZ2WkdQUjBCVTBxVVFYMkR2RllWWTRtMjk3TVlqU0RFUFZZaFRKV2h1SmdnYmlzdVd4R0tkeDdhQVlrT2RNUzZYUDhyaU5xa1FCdzFIakZxSkVTcTBpb2ZaeUpFcjRwX1RuUlFVSlpKMVhyeDRjNzlBU1ZGUEdhNk1WYU45TXE2NVNnMlo3bUZaQWVSaWNtVFRYSHA2aFZGNE16NGdia1JraTNMR1J2STcwMzZ3cnc5UnBscDE?oc=5","date":"2022-08-26","type":"trial","source":"BioSpace","summary":"Kira Pharmaceuticals to Present New Preclinical Data on Lead Asset KP104 at the 2022 European Meeting on Complement in Human Disease Conference - BioSpace","headline":"Kira Pharmaceuticals to Present New Preclinical Data on Lead Asset KP104 at the 2022 European Meeting on Complement in H","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE4zSEE0aGV3dlFNRkhiN3lWMXBMQTI1M1RmbVZBT0Q3U2RNanFvVzdDdThWeENfZ1Rlc3pHSEJfN281bjZfTjVmb08yNkhJSVE5bjBFVHNUbExZRFRIRXBR?oc=5","date":"2022-06-03","type":"pipeline","source":"Nature","summary":"Untangling the changing impact of non-pharmaceutical interventions and vaccination on European COVID-19 trajectories - Nature","headline":"Untangling the changing impact of non-pharmaceutical interventions and vaccination on European COVID-19 trajectories","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNZTR4eXJwa0t4WW02T3NuYW94ZDNwZjJFZGhRQXppZ0w1OTIxQTVFX0oxclR0QUJrZzRVUmpudzVleUxsSlB5QUhTb0RGdWNGR2stNXFsYTg0dlJPU2JHbEZXcEhxemlvZUxGQkp0dFp5VW10QW5wa3lieXZBS1Vvd2JqUkNsaWc?oc=5","date":"2021-10-06","type":"pipeline","source":"Contract Pharma","summary":"CEO Spotlight: Minzhang Chen, WuXi AppTec & WuXi STA - Contract Pharma","headline":"CEO Spotlight: Minzhang Chen, WuXi AppTec & WuXi STA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxPaFZGbWRJUE1QRm5nbW1CSzBudUo5Uk85RTlwczJhc1dBeUJFMVNPUk03QkpGaXE2Sm5POXA5V2Exdm1ZdkxhYWJYTmJfS0NKZ2hWZmpHSzlLQ1F6d2FhaC1VR0RHbGEzdTh1SDh4RVA2ak5vVTdyOFhMTm52WWhLcVp4cEpyWmlwV3QxZkl5STU2OUdqUWY3SWpXVFJOeWlUaG9mTVNqWjBYQ3BZQi1odW1RYU1wdWEtWWRKMjBjcE9MNFljNkpxV1NWYw?oc=5","date":"2020-08-04","type":"pipeline","source":"PharmTech.com","summary":"Solubility, Polymorphism, Crystallinity, Crystal Habit, and Drying Scheme of (R, S)-(±)-Sodium Ibuprofen Dihydrate - PharmTech.com","headline":"Solubility, Polymorphism, Crystallinity, Crystal Habit, and Drying Scheme of (R, S)-(±)-Sodium Ibuprofen Dihydrate","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2013-02-01","type":"pipeline","source":"South China Morning Post","summary":"Opinion | Pharmaceutical company loses 1b yuan after 140-word Weibo message - South China Morning Post","headline":"Opinion | Pharmaceutical company loses 1b yuan after 140-word Weibo message","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":2,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}